Clinical translation of 177Lu-labeled PSMA-617: Initial experience in prostate cancer patients

Preliminary clinical studies indicated the promising potential of the agent for theranostic applications. However, further investigations in large pool of patients are warranted to establish the theranostic potential of the agent.